Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease

BACKGROUND: Accumulative evidence showed that gut microbiota was important in regulating the development of nonalcoholic fatty liver disease (NAFLD). Hugan Qingzhi tablet (HQT), a lipid-lowering and anti-inflammatory medicinal formula, has been used to prevent and treat NAFLD. However, its mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Waijiao, Yao, Xiaorui, Xia, Fan, Yang, Miaoting, Chen, Zhijuan, Zhou, Benjie, Liu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323444/
https://www.ncbi.nlm.nih.gov/pubmed/30671174
http://dx.doi.org/10.1155/2018/7261619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323444/
https://www.ncbi.nlm.nih.gov/pubmed/30671174
http://dx.doi.org/10.1155/2018/7261619

Ejemplares similares